PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Feb-2025 Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris Nxera Pharma
28-Feb-2025 UK must do more on access to rare disease medicines, says ABPI ABPI
28-Feb-2025 Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals Marinomed Biotech AG
27-Feb-2025 Issue and re-purchase of class C shares for shareholder program Oncopeptides AB
27-Feb-2025 Former Apple and Intel Executive Michael Bell Joins Chemify as Chief Technology Officer Chemify
27-Feb-2025 Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics for Radioisotope Supply and Contract Development and Manufacturing of Bicycle Radio Conjugates Eckert & Ziegler SE
27-Feb-2025 Douglas AG: Kreke Family, via Lobelia Lux S.à r.l., changes indirect participation in Douglas AG into a direct participation Douglas AG
27-Feb-2025 Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury Tiziana Life Sciences
27-Feb-2025 MEDICLIN presents preliminary figures for the 2024 financial year MEDICLIN AG
27-Feb-2025 Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe Brainomix
27-Feb-2025 UK Healthcare M&A hits the ground running in January 2025 Heligan Group
27-Feb-2025 Pascal Keller-Bossart becomes new CEO of the SITS Group SITS Group
27-Feb-2025 DocMorris AG: ECJ Ruling on advertising for prescription medicines DocMorris AG
27-Feb-2025 Thermo Fisher Scientific Launches CorEvitas Clinical Registry and Biorepository in Systemic Lupus Erythematosus Thermo Fisher Scientific
27-Feb-2025 Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma Regeneron Pharmaceuticals
27-Feb-2025 Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumour mutation in SERENA-6 Phase III trial AstraZeneca
27-Feb-2025 Evotec announces change in Management Board Evotec
26-Feb-2025 Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector Cannovum Cannabis AG
26-Feb-2025 Beiersdorf Aktiengesellschaft: Beiersdorf announces another share buyback program Beiersdorf Aktiengesellschaft
26-Feb-2025 Biotest AG publishes preliminary business figures - 2024 forecasts partially exceeded Biotest AG